Molecular Partners AG Enterprise Value to EBITDA (EV/EBITDA) on July 25, 2025: 0.20

Molecular Partners AG Enterprise Value to EBITDA (EV/EBITDA) is 0.20 on July 25, 2025, a -242.33% change year over year. EV/EBITDA ratio compares the enterprise value to the EBITDA; lower suggests more favorable company valuation.
  • Molecular Partners AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is 0.76 on July 25, 2025, which is 288.39% above the current Enterprise Value to EBITDA (EV/EBITDA).
  • Molecular Partners AG 52-week low Enterprise Value to EBITDA (EV/EBITDA) is -0.52 on July 25, 2025, which is -363.12% below the current Enterprise Value to EBITDA (EV/EBITDA).
  • Molecular Partners AG average Enterprise Value to EBITDA (EV/EBITDA) for the last 52 weeks is 0.24.
Key Data
Date Enterprise Value to EBITDA (EV/EBITDA) Free Cash Flow Yield Dividend Yield Market Capitalization